Clinical Trials Directory

Trials / Completed

CompletedNCT05599646

Pedometer-Based Walking Intervention on Physical Activity Among Hemodialysis Patients

Effects of Gamified Versus Traditional Pedometer-Based Walking Intervention on Physical Activity, Fatigue and Sleep Quality Among Hemodialysis Patients: A Quasi-Experimental Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
94 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Patients undergoing HD are mostly physically inactive and have reduced functional capacities compared to healthy individuals which contributes to a decreased quality of life and consequently increases the risk of mortality

Detailed description

Physical activity has been shown to have various positive effects on HD patients . Some of the important benefits linked to exercise include an improvement in physical fitness , aerobic capacity , dialysis adequacy (measured as urea Kt/V) , quality of life , and reduced depressive symptoms .Walking can be considered as the most natural form of PA as it is easily performed by everyone except for the seriously disabled or very frail. Smartphones and their embedded computer technologies are increasingly being used to promote physical activity. Gamification presents itself as a promising approach to overcome a loss of interest, increase user engagement , raise the quality of health behaviors , and motivate users to use mHealth apps for a sustained period

Conditions

Interventions

TypeNameDescription
BEHAVIORALtraditional pedometer based walking interventionParticipants were recommended to monitor their step count using traditional pedometer and to increase their steps by 10% compared with the prior week. the intervention will continue for 12 weeks
BEHAVIORALgamified pedometer based walking interventionParticipants were recommended to monitor their step count using gamified pedometer, earn money, compete friends and to increase their steps by 10% compared with the prior week. the intervention will continue for 12 weeks

Timeline

Start date
2022-10-31
Primary completion
2023-09-30
Completion
2025-03-30
First posted
2022-10-31
Last updated
2025-05-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05599646. Inclusion in this directory is not an endorsement.